Related by context. All words. (Click for frequent words.) 84 Clinical Oncology ASCO Annual 81 Hematology ASH 81 Clinical Oncology Annual Meeting 79 Clinical Oncology 76 Hematology ASH Annual Meeting 75 Hematology Annual Meeting 72 Clinical Oncologists 71 Hematology Meeting 70 Radiation Oncology ASTRO 69 Cancers Symposium 68 Hematology ASH Meeting 68 Medical Oncology ESMO 67 ASCO Annual Meeting 67 Hematology 67 ASCO 65 Therapeutic Radiology 65 Digestive Disease Week DDW 64 Nephrology Renal Week 64 Digestive Disease Week 64 Scientific Sessions 63 Connective Tissue Oncology 63 Gastrointestinal Cancers Symposium 62 Neurology AAN 62 Genitourinary Cancers Symposium 62 Hypertension ASH 62 Interventional Radiology SIR 62 nd Annual Meeting 62 ASH Annual Meeting 62 Breast Surgeons ASBS 62 AACR 62 American Roentgen Ray 61 Clinical Oncology ASCO Gastrointestinal 61 Pharmaceutical Scientists AAPS 61 AACR #nd Annual Meeting 61 Microbiology ASM 60 Reproductive Medicine ASRM 60 Oncology ASTRO 60 Cardiology ESC 60 Scientific Session 60 Anesthesiologists ASA 60 AACR NCI EORTC 60 Breast Surgeons 60 Anesthesiologists ASA Annual Meeting 60 Nephrology ASN Renal 60 Scientific Meeting 60 Human Genetics ASHG 60 EORTC NCI AACR 60 AHA Scientific Sessions 60 San Antonio Breast Cancer 60 Gene Therapy ASGT 60 League Against Rheumatism 59 Mineral Research ASBMR 59 Society CTOS 59 st Annual Meeting 59 Clinical Oncology Gastrointestinal Cancers 59 AACR #st Annual Meeting 59 Mass Spectrometry ASMS 59 Clinical Chemistry AACC 59 Neuro Oncology SNO 59 Nephrology ASN 59 Cancer iSBTc 59 Cardiology ACC 59 Liver EASL 59 Annual Scientific Sessions 58 Stem Cell Research ISSCR 58 Retina Specialists 58 ASCO GI 58 Arteriosclerosis Thrombosis 58 Liver Diseases AASLD 58 Echocardiography ASE 58 Therapeutic Radiation 58 System Pharmacists ASHP 57 Biological Therapy 57 Gynecologic Oncologists 57 EORTC NCI AACR Symposium 57 Chemotherapy ICAAC 57 Cardiology ESC Congress 57 ICAAC 57 Diabetes EASD 57 AASLD 57 Anesthesiologists Annual Meeting 57 Gynecologic Oncologists SGO 57 Clinical Oncologists ASCO 57 Ophthalmology AAO 57 Rheumatology ACR Annual 57 Molecular Targets 57 ESMO 57 Interventions SCAI 57 SABCS 56 Gastrointestinal Endoscopy ASGE 56 Neurology Annual Meeting 56 Pharmacoeconomics 56 Liver Disease AASLD 56 Cell Biology ASCB 56 CTRC AACR San Antonio 56 ECTRIMS 56 Healthcare Epidemiology 56 #th Annual Interscience 56 Antimicrobial Agents 56 Gastrointestinal Endoscopy 56 AUA Annual Meeting 56 AACR Annual Meeting 56 American Urological Association 56 Hypertension ESH 56 Liver Diseases 56 Thoracic Surgeons 56 ADA Scientific Sessions 55 American Thoracic Society 55 Surgical Oncology SSO 55 annual Transcatheter Cardiovascular 55 Heart Rhythm 55 Breast Cancer Symposium 55 Controlled Release 55 ICAAC IDSA 55 AACR San Antonio 55 Cardiovascular Angiography 55 Vascular Biology ATVB 55 Dermatology AAD 55 Maternal Fetal Medicine SMFM 55 Transcatheter Cardiovascular Therapeutics 55 Cardiovascular Anesthesiologists 55 Endocrine Society ENDO 55 Nephrology Annual Meeting 55 #st Annual Meeting 55 Transcatheter Cardiovascular Therapeutics TCT 55 ISPOR 55 ASCO Genitourinary Cancers Symposium 55 Clinical Endocrinologists AACE 55 Late Breaker 54 Clinical Pathology ASCP 54 Urology EAU 54 EORTC NCI 54 EULAR 54 Menopause Society NAMS 54 Therapeutics TCT scientific 54 Ophthalmology ARVO 54 Neuropsychopharmacology 54 Medicine SIIM 54 ASGT 54 Investigative Dermatology 54 Prostate Cancer Symposium 54 ECCO ESMO 54 Retina Specialists ASRS 53 enzastaurin 53 SUCCEED trial 53 Digestive Diseases Week 53 Neuro Oncology 53 ASTRO Annual Meeting 53 Gastroenterology ACG 53 Plastic Surgeons ASPS 53 #nd Annual Meeting 53 Thoracic Surgeons STS 53 Gynecologic Investigation 53 Interventional Radiology 53 Nephrology JASN 53 Thoracic Oncology 53 ASCO Breast Cancer 53 Neck Surgery Foundation 53 Heart Failure Society 53 CROI 53 FDA Oncologic Drugs 53 AACR symposium 53 Clinical Chemistry 53 European CanCer Organisation ECCO 53 EuroPCR 53 ORAL Sync 53 EASL 53 Rheumatology Annual 52 Breast Cancer Symposium SABCS 52 Alzheimer Disease ICAD 52 System Pharmacists Midyear 52 Outcomes Research ISPOR 52 America RSNA 52 ongoing Phase 1b 52 Neurological Surgeons AANS 52 Nephrology CJASN 52 Rheumatology 52 Pediatric Academic Societies PAS 52 Experimental Biology 52 PROSTVAC TM 52 pertuzumab 52 ASCO GU 52 CLARITY study 52 Oncology Nursing 52 dose escalation clinical 52 Lung Transplantation 52 Medical Oncology 51 Cachexia 51 TASKi2 51 Hygiene ASTMH 51 Gemzar ® 51 Cardiology 51 Cellular Therapy ISCT 51 & Immunology AAAAI 51 Phase 2a clinical 51 AAN Annual Meeting 51 rALLy trial 51 UEGW 51 Molecular Pathology AMP 51 Percutaneous Cardiovascular Interventions 51 Spine Society 51 ASCO abstract 51 KRN# 51 Chicago Multidisciplinary Symposium 51 Annual Transcatheter Cardiovascular 51 #nd EORTC NCI 51 ECCMID 51 Therapeutics TCT 51 PROVENGE sipuleucel T 51 Toxicology SOT 51 Cloretazine ® 51 Dermatologic Surgery 51 Neurological Surgeons 51 Endocrine Society #st 51 Hyperthermic Oncology ESHO 51 ASBMR 51 Lysosomal Disease Network 51 Minimally Invasive Cardiothoracic Surgery 51 Symposium SABCS 51 alvespimycin 50 Rheumatology ACR 50 Clinical Microbiology 50 Clinical Virology Symposium 50 Cardiology Scientific Sessions 50 Endocrine Society Annual Meeting 50 assessing T DM1 50 metastatic hormone refractory 50 Association Executives ASAE 50 Radiological Society 50 Phase 2b trial 50 Nuclear Cardiology ASNC 50 Phase #/#a trial 50 AAO HNSF Annual Meeting 50 ELACYT 50 Investigative Pathology 50 Gynecologic Oncology Group 50 Interscience Conference 50 Aesthetic Plastic Surgery ASAPS 50 BiTE R 50 Clinical Oncology JCO 50 Advanced Neuroendocrine Tumors 50 resistant ovarian cancer 50 Oncologic Drugs Advisory 50 NASDAQ CXSP announced 50 picoplatin 50 sorafenib tablets 50 Brentuximab Vedotin SGN 50 Endocrine Society #nd 50 metastatic castration resistant 50 Cardiovascular Computed Tomography 50 American Psychosomatic Society 50 Thoracic Surgery AATS 50 BCIRG 50 cetuximab Erbitux 50 Bariatric Physicians ASBP 50 Liver Meeting 50 Respiratory Society 50 Amrubicin 50 Endoscopic Surgeons 50 Addiction Medicine ASAM 50 Endovascular Therapy ISET 50 XL# SAR# 50 HIMSS Healthcare 50 TACI Ig 50 Phase Ib II 50 HCV SPRINT 49 Plant Biologists ASPB 49 ACR ARHP 49 perifosine 49 NASDAQ SLXP today 49 LymphoStat B 49 aflibercept 49 System Pharmacists 49 Experimental Biology FASEB 49 Recurrent Chest Wall 49 Colposcopy 49 Pirfenidone 49 Roentgenology 49 trastuzumab DM1 T DM1 49 Gastrointestinal Cancer 49 NO# [002] 49 Plastic Surgeons ASPS Plastic 49 Bariatric Surgery ASBS 49 Endoscopic Surgeons SAGES 49 zanolimumab 49 Gastroenterology ACG Annual 49 SCAI Annual 49 Cervical Pathology 49 sipuleucel T 49 rALLy clinical trial 49 Quinamed 49 ARVO 49 ENDO 49 Society HIMSS 49 Vascular Surgery SVS 49 refractory multiple myeloma 49 Vascular Annual Meeting 49 Dermatologic Surgery ASDS 49 www.asco.org 49 Malignant Lymphoma 49 phase IIa clinical 49 Society Nephrology CJASN 49 International Myeloma Workshop 49 Jupiter Tequesta Orchid 49 evaluating REVLIMID 49 Paediatric Oncology SIOP 49 Experimental Biology Annual Meeting 49 Genasense 49 ENDEAVOR III 49 Pediatric Academic Societies 49 HORIZONS AMI trial 49 Medicine AAPM 49 ON #.Na 49 BIO Investor 49 Malignant Mesothelioma 49 Inflammatory Bowel Diseases 49 BIO InvestorForum 49 HORIZONS AMI 49 EASD 49 CR# vcMMAE 49 Reolysin 49 Combination REOLYSIN R 49 RSNA 49 CRLX# 49 Midyear Clinical Meeting 49 Cystic Fibrosis Conference NACFC 49 NEUVENGE 49 prostate cancer HRPC 49 phase IIb study 49 docetaxel chemotherapy 48 ® DDW 48 forodesine 48 recurrent malignant glioma 48 Phase 2a trial 48 BIOCOM Investor Conference 48 oral ridaforolimus 48 Equine Practitioners Convention 48 Spine Arthroplasty Society 48 Vascular Biology 48 Ophthalmology Annual Meeting 48 relapsed multiple myeloma 48 HyQ 48 ACR ARHP Annual 48 phase IIb 48 neratinib 48 HER2 positive metastatic breast 48 #th Interscience Conference 48 viral kinetic 48 ProSavin 48 Retroviruses 48 alvimopan 48 ToGA 48 EGEN 48 Remote Sensing ASPRS 48 Nanomedicine ASNM 48 rivaroxaban Xarelto 48 Immunology Annual Meeting 48 IRX 2 48 America HFSA 48 EULAR Annual 48 AACR Frontiers 48 CALGB 48 sorafenib Nexavar 48 Biomolecular Sciences SBS 48 Antimicrobial Chemotherapy 48 NCCTG N# 48 DDW ® 48 AIR2 Trial 48 dose escalation trial 48 BRIM2 48 Surgeons ACS 48 Refractive Surgery ASCRS 48 Nasdaq ENZN 48 Chemical Society 48 registrational Phase 48 Pain Medicine AAPM 48 Phase 1b trial 48 oral Xeloda 48 International Papillomavirus 48 BioPharm America 48 histone deacetylase HDAC inhibitor 48 elotuzumab 48 th Interscience Conference 48 pralatrexate 48 AAPM 48 BRIM3 48 trabectedin 48 dasatinib Sprycel 48 AVADO 48 placebo controlled clinical 48 Lung Transplantation ISHLT 48 bevacizumab Avastin 48 EUROGIN 48 mRCC 48 SAWC WHS 48 OncoVEX GM CSF 48 AACR Meeting 48 phase 2a 48 Carfilzomib 48 Gastroenterology Nurses 48 SCCHN 48 Radiation Therapy Oncology 48 Chemophase 48 INCB# [001] 48 Nexavar sorafenib 48 AACR EORTC NCI 48 Nasdaq DNDN 48 Hepatology journal 48 ADVANCE PD 48 Menopause Society 48 Integrative Oncology 48 PERSEUS 48 ganetespib 48 metastatic HRPC 48 axitinib 48 Transplantation AST 48 metaglidasen 48 Information Display SID 48 fosbretabulin 48 TG MV 48 Inc. Nasdaq VRUS 48 evaluating tivozanib 48 Bariatric Surgery ASMBS 48 adecatumumab 48 Randomized Phase 48 EOquin TM 47 Transplant Surgeons ASTS 47 Clinical Cancer 47 teriflunomide 47 Infectious Diseases ECCMID 47 USpella 47 AASLD Meeting 47 Interventional Pain Physicians 47 abstracts summarizing 47 Phase 2b study 47 Erbitux 47 phase IIb clinical 47 Golf Course Architects ASGCA 47 CTAP# Capsules 47 lintuzumab 47 FOLOTYN 47 Immunology AAAAI 47 Abstract # 47 SAEM Annual Meeting 47 Solorel TM 47 oral proteasome inhibitor 47 Aflibercept 47 Targretin 47 Interventional Pain Physicians ASIPP 47 Doxil ® 47 EORTC 47 AVERROES 47 pazopanib 47 GRN#L 47 standard chemotherapy regimen 47 Movement Disorder 47 recurrent GBM 47 Sirion Therapeutics 47 Chemotherapy ICAAC Infectious Diseases 47 Vacuum Coaters 47 Opportunistic Infections CROI 47 hormone refractory metastatic prostate 47 Inc. Nasdaq OPTR 47 CombAT 47 EXPAREL ™ 47 Gastroenterology 47 vidofludimus 47 Tanespimycin 47 ACUITY trial 47 Exploration Geophysicists SEG 47 phase IIa 47 Global Healthcare Unplugged 47 maximally tolerated dose 47 Pediatric Academic Society 47 Aesthetic Mesotherapy 47 Hand ASSH 47 & OTO EXPO 47 Endovascular Therapy 47 Cancer EORTC 47 Cardiology Heart Failure 47 huC# DM4 47 HuMax EGFr 47 multicenter Phase 47 platinum refractory 47 anticancer compound 47 antibody MT# 47 Surgical Oncology 47 SPIRIT IV 47 NCCN Clinical Practice 47 PRECISE 47 palifosfamide 47 Safety Engineers ASSE 47 ILLUMINATE 47 PRNewswire FirstCall Tercica 47 Phase 2b 47 Gene Therapy 47 Annual Interscience Conference 47 Phase IIB clinical 47 YONDELIS 47 Orthopedic Surgeons AAOS 47 randomized Phase III 47 Maternal Fetal Medicine 47 Urocortin 2 47 Ophthalmology ARVO Annual Meeting 47 multicenter clinical 47 Gynecologic Laparoscopists 47 PEG SN# 47 obatoclax 47 MEND CABG 47 Canaccord Adams Hepatitis C 47 Clinical Endocrinologists 47 blinatumomab 47 Immunologists 47 atrasentan 47 relapsed refractory multiple myeloma 47 Heart Assn 47 website www.asco.org 47 HuMax CD4 47 Phase III ALLEGRO 47 Phase #b/#a clinical 47 Liver Disease 47 trastuzumab Herceptin 47 Phase III psoriasis 47 abstracts 47 NASDAQ PCYC 47 Annual BIO 47 metastatic melanoma 47 pemetrexed Alimta 47 entinostat 47 tanespimycin 47 Plicera 47 ISHLT 47 Applied Spectroscopy 47 iclaprim 47 taxane resistant 47 Radiologic Technologists ASRT 47 AP# [003] 47 Annual ICAAC 47 recurrent glioma 47 CUSTOM III 47 IL# PE#QQR 47 Genasense ® 46 BR.# 46 GASTRO 46 Ceflatonin 46 Phase 2a 46 Diabetologia 46 fidaxomicin Phase 3 46 atacicept 46 Vectibix 46 metastatic colorectal cancer 46 Cloretazine R VNP#M 46 Gynecologic Oncology 46 Anti Infective Drugs 46 International Neuropsychological Society 46 AS# amonafide L malate 46 AACR NCI EORTC Molecular 46 RTOG 46 ponatinib 46 Hsp# Inhibitor 46 panitumumab 46 Geriatric Psychiatry 46 Nasdaq PCYC 46 Lymphoseek ® 46 Venereology EADV 46 Cardiovascular Computed Tomography SCCT 46 Group RTOG 46 Cellular Therapy 46 Experimental Biology EB 46 L BLP# 46 Onrigin 46 Multiple Sclerosis ECTRIMS 46 www.aacr.org 46 voreloxin 46 CARE HF 46 LUX Lung 46 Gynecologic Cancer Society 46 HGS ETR1 46 EURIDIS 46 MERLIN TIMI 46 CANCER peer reviewed 46 pain palliation 46 RGB # 46 oral rivaroxaban 46 metastatic renal cell carcinoma 46 ACC.# 46 carfilzomib 46 Lung Cancer IASLC 46 Food Technologists 46 galiximab 46 INSPIRE Trial Phase III 46 Cloretazine R 46 Cancer Immunotherapy 46 Poster Discussion 46 vascular disrupting agent 46 Oak Brook Ill. RSNA.org 46 Imprime PGG ® 46 journal Antimicrobial Agents 46 Ambrisentan 46 Therapeutic Radiation Oncology 46 preclinical efficacy 46 brivaracetam 46 DASISION 46 Clinical Dermatology 46 Wound Healing Society 46 Inc. NASDAQ HEPH 46 FOLFOX6 chemotherapy regimen 46 AAPS Annual Meeting 46 CALGB # [002] 46 ASCO Prostate Cancer 46 Venous Forum 46 Vertex telaprevir 46 Chest Pain Centers 46 MOZOBIL 46 #rd Annual CTRC 46 COU AA 46 Hexvix 46 AABB Annual Meeting 46 ENESTnd 46 Minimally Invasive Gynecology 46 PRNewswire FirstCall Genta Incorporated 46 orally inhaled migraine 46 Proxinium TM 46 Gynecological Cancer 46 VEITHsymposium 46 Phase III VISTA 46 Prostate AdenoCarcinoma Treatment 46 heavily pretreated 46 Developmental Therapeutics Immunotherapy 46 Zybrestat 46 pediatric sarcoma 46 ixabepilone 46 Neurological Surgeons Annual Meeting 46 registrational 46 Apoptone 46 ASCRS 46 Respiratory Care AARC 46 Endocrine Society 46 Zarnestra 46 IRESSA 46 randomized discontinuation trial 46 Biologic Therapy 46 Surgery ASLMS 46 MDV# 46 CBLC# 46 Neuropsychopharmacology ACNP 46 EVEREST II 46 NASDAQ CYTK announced 46 CCX# 46 thetreatment 46 Glufosfamide 46 CHEST 46 trastuzumab DM1 46 ISTH 46 Avastin bevacizumab 46 Ovarian PLCO Cancer 46 PSMA ADC 46 Breaking Clinical Trials 46 Allergy Asthma 46 J Clin Oncol 46 CRMD# 46 satraplatin Phase 46 Molecular Medicine Tri 46 hematologists 46 Br J Cancer 46 Hedgehog Pathway Inhibitor 46 CoFactor 46 DAVANAT 46 eniluracil 46 Folfox 46 CLARITY TIMI 46 International Cartilage Repair 46 Phase Ib clinical 46 ASCO Gastrointestinal Cancers Symposium 46 Rheumatology Annual Meeting 46 Epilepsy Society 46 trials RCTs 46 phase IIb trial 46 huN# DM1 46 Neurological Societies 46 Nephrology 46 pan HDAC inhibitor 46 catheter occlusion 46 INCB# [002] 46 Talabostat 46 clinical trial 46 Hair Restoration Surgery 46 Haemostasis ISTH 46 Immunology ACAAI 46 pharmacokinetic PK study 46 metastatic CRC 46 Neck Cancer 46 PEGylated interferon beta 1a 46 Headache Society 46 CA4P 46 radezolid 46 ZACTIMA 46 FOLOTYN ® 46 Bioral ® 46 Ambulatory Pediatrics 46 Semafore Pharmaceuticals 46 KRAS status 46 Azedra 45 RE LY 45 mitogen activated ERK kinase 45 immunotherapeutic agent 45 Orthopaedic Surgeons AAOS 45 Molecular Cancer 45 deforolimus 45 Nasdaq SGMO announced 45 boceprevir 45 CYT# potent vascular disrupting 45 NCCTG 45 Metastatic Melanoma 45 Phase Ib study 45 XL# XL# XL# 45 SIR Spheres 45 CUSTOM II 45 Reproductive Medicine 45 randomized Phase IIb 45 Urologic Oncology SUO 45 Clinical Psychopharmacology 45 trastuzumab emtansine T DM1 45 depsipeptide 45 ASA# 45 Landscape Architects ASLA 45 Gaylord Palms Hotel 45 Taxotere ® 45 ImmunoVEX HSV2 45 Long Awaited Reality 45 APPRAISE 45 Rheumatology EULAR 45 American Physiological Society 45 Anesthesiologists 45 Randomized Phase II 45 Related Disorders ICAD 45 Nasdaq EXAS today 45 SPIRIT FIRST 45 ABCSG 45 rosuvastatin Crestor 45 LibiGel testosterone gel 45 Immunotherapeutic 45 Targeted Anticancer Therapies 45 Panzem R NCD 45 Nasdaq SNSS 45 Critical Care Medicine 45 ICON7 45 relapsing multiple sclerosis 45 Inc. Nasdaq INFI 45 EFNS 45 brentuximab vedotin 45 multiple myeloma MM 45 Femara letrozole 45 Celgene Revlimid 45 Education ISTE 45 glufosfamide 45 TRO# 45 Pemetrexed 45 Dacogen injection 45 Daniel Von Hoff 45 OPAXIO 45 Ceflatonin R 45 brentuximab vedotin SGN 45 iSBTc 45 LymphoStat B TM 45 Pediatric Radiology 45 Nasdaq REGN 45 oral prodrug 45 phase IIIb 45 Cell Transplant 45 rEEG 45 Lipid Research 45 Opportunistic Infections 45 Inc. Nasdaq AMLN 45 th Annual Interscience 45 Cardiostim 45 chemotherapy gemcitabine 45 American Gastrointestinal Endoscopic 45 Annual Institutional Investor 45 Nordic ACTI 45 interferon gamma 1b 45 journal Arteriosclerosis Thrombosis 45 Genome Biology 45 ovarian suppression 45 Cell Therapy 45 YONDELIS R 45 ustekinumab 45 journal Menopause 45 delafloxacin 45 Aplidin 45 Cambridge Healthtech Institute 45 Radiology ECR 45 ERA EDTA 45 mg administered orally 45 amrubicin 45 ZOLINZA 45 HRPC 45 Phase 2b RESTORE CLI 45 Intervention Effectiveness 45 chronic lymphocytic leukemia CLL 45 Erbitux cetuximab 45 HCV polymerase inhibitors 45 NAREIT Investor 45 iniparib 45 SPIRIT III 45 ARVO Annual Meeting 45 ePRO 45 hormone refractory prostate cancer 45 lexidronam injection 45 PANVAC VF 45 drug eluting stent DES 45 Romiplostim 45 Bipolar Disorders 45 farletuzumab 45 CLL8 45 Gynecological Oncologists 45 Management SCDM 45 HUPO 45 Regional Anesthesia 45 Yondelis 45 Plastic Surgeons 45 Professional Sleep Societies 45 PXD# 45 Lancet Oncology 45 decitabine 45 Healthcare Publication Editors 45 Diabetic Macular Edema 45 Nasdaq DVAX 45 Phase III ADT 45 Fifth Decennial International 45 prostate cancer mCRPC 45 Arthroscopy Association 45 novel VDA molecule 45 Taxotere R 45 Cardiovascular Interventions 45 Xinlay 45 ESTRO 45 Pediatric Otolaryngology 45 sunitinib Sutent 45 R roscovitine 45 Human Brain Mapping 45 Maxillofacial Surgeons 45 cabozantinib 45 Antiviral Research 45 antitumor activity 45 T DM1 45 APOPTONE 45 Inc. NASDAQ AGIX 45 ® cetuximab 45 Biodefense Vaccines 45 Echocardiography 45 Addiction Medicine 45 refractory chronic myeloid 45 dasatinib 45 Aryplase 45 SWOG 45 Allovectin 7 45 REITWeek 45 phase Ib 45 PSN# [002] 45 sunitinib malate 45 Phase 1b 45 including eniluracil ADH 45 Biological Psychiatry 45 Cardiovascular Therapeutics 45 DU #b 45 seliciclib CYC# 45 Chronic Lymphocytic Leukemia 45 Urology EAU Congress 45 ZYBRESTAT 45 Diabetes EASD Annual Meeting 45 Phase III AFFIRM 45 Zenvia Phase III 45 Geriatric Oncology 45 varespladib 45 cediranib 45 HIMSS# 45 Chest Pain Centers SCPC 45 HCV RESPOND 2 45 midstage clinical 45 FOCIS 45 Society Nephrology JASN 45 Nasdaq GNTA 45 Diabetes Educators AADE 45 Dendreon Provenge 45 Women Engineers SWE 45 bazedoxifene conjugated estrogens 45 TRANSFORMS 45 Nasdaq OPTR 45 Arch Surg 45 SYNTAX trial 45 Experimental NeuroTherapeutics 45 Food Technologists IFT 45 PreCISe 45 ALN TTR 45 motexafin gadolinium Injection 45 #th Annual Retrovirus 45 Everolimus 45 Clinical Trials Update 45 candidate epratuzumab 45 Printable slides 44 Breast Disease 44 MEK inhibitor 44 Aplidin R 44 HQK 44 randomized controlled Phase 44 CIMZIA ™ 44 Neurology 44 Ophthalmic Drugs Advisory 44 Fondaparinux 44 Reproductive Medicine specify 44 NAREIT REITWeek 44 ISA# [002] 44 Infectious Diseases Society 44 Physiology Regulatory Integrative 44 Certican 44 PITTCON 44 CTRC AACR 44 II Clinical Trial 44 Inc. Nasdaq SGEN 44 ThermoDox ® clinical 44 Artificial Internal Organs 44 peginesatide 44 Annual AIFA 44 gemcitabine Gemzar 44 Phase Ib clinical trials 44 NSABP 44 Biomolecular Sciences 44 ASH Abstract # 44 MGd 44 mCRC 44 ErbB2 positive 44 Sipuleucel T 44 perifosine KRX 44 ABRF 44 Abiraterone 44 mCRC patients 44 Canaccord Adams Musculoskeletal 44 gastrointestinal stromal tumors GIST 44 PEARL HF 44 Paediatric Infectious Diseases 44 Tocosol Paclitaxel 44 Exposition ACE# 44 ThermoDox R 44 Elvitegravir 44 PROLARIS 44 ENDEAVOR IV 44 AA Amyloidosis 44 www.hematology.org 44 Microplasmin 44 SAR# [004] 44 Natalizumab 44 American Sociological 44 epigenetic therapies 44 Traficet EN 44 Experimental Biology FASEB Journal 44 MabThera rituximab 44 OXi# 44 Inhalation Solution 44 Varespladib 44 RECORD1 44 proteasome inhibitor 44 investigational immunotherapy 44 NCCN guidelines 44 Clinical Trial Results 44 BARI 2D 44 Gleevec imatinib mesylate 44 oral FTY# 44 ELIQUIS 44 Aesthetic Plastic Surgery 44 resistant hormone refractory 44 HFSA Annual 44 Actemra 44 Mammalogists 44 Hsp# inhibitor 44 MEND CABG II 44 PROTECT II 44 Dermatology 44 ProLindac 44 multicenter randomized Phase 44 Urologic Oncology 44 trastuzumab 44 Angiology 44 NSABP C 44 Comprehensive Cancer Network 44 Phase Ib 44 Xcytrin R 44 entitled Synergistic 44 Rectal Surgeons 44 Molecular Pathology 44 sulodexide 44 aliskiren 44 Cardiovascular Magnetic Resonance 44 HGS# 44 NCCN 44 PROTECT AF 44 sapacitabine 44 targeting CD# 44 ALN VSP